Centricity Vision announced new ZEPTOLink enhancements, reducing treatment time by up to 60%. These updates, aimed at ...

Bausch + Lomb receives US FDA approval for enVista Envy full range of vision intraocular lens: Vaughan, Ontario Tuesday, October 15, 2024, 17:00 Hrs [IST] Bausch + Lomb Corporatio ...

The approval comes amidst rumours of a potential private equity buyout of the Canadian company, whose parent company has ...

If you're thinking about getting cataract surgery, here's what a renowned ophthalmologist says you should know.

The FDA granted approval to the enVista Envy full range of vision IOLs following Canadian approval in May 2024.

Shares in Bausch + Lomb were higher after the company received approval from the Food and Drug Administration for its enVista Envy full range of vision intraocular lens. Shares were recently up 23% at ...

The lens features a freeform diffractive surface designed for clear vision at near, intermediate, and distant ranges.

A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.The global Intraocular Lens (IOL) market ...

Over and above, 66 suspects were arrested in CIT related cases, making a combined number of 115 arrests for CIT and related ...

Most people over age 60 eventually get cataracts. This common condition typically starts very slowly, so those who don’t have regular eye exams may not realize what’s going on inside their eyes.

Bausch + Lomb said enVista Envy intraocular lenses will be commercially available in the U.S. on a limited basis in the coming weeks and more broadly in 2025. The company is in the process of seeking ...